International Immunology, Vol. 12, No. 8, 1173-1182,
August 2000
© 2000 Japanese Society for Immunology
RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation
MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK
1 British Biotech Pharmaceuticals Ltd, Oxford OX4 5LY, UK
Correspondence to: V. Appay
RANTES (regulated upon activation, normal T cell expressed and secreted) is released by cytotoxic T lymphocytes (CTL), and is a potent chemoattractant factor for monocytes and T cells, also known for its ability to suppress HIV infection. At micromolar concentration, RANTES is able to activate leukocytes, and, paradoxically, to enhance HIV infection in vitro. These latter properties are dependent on its ability to self-aggregate. In order to understand further the mechanism of RANTES-induced activation, the effects of both aggregated and disaggregated RANTES on antigen-specific CD8+ clones were studied in comparison with the effects of specific antigens and in the presence of specific inhibitors of RANTES-mediated activation. We observed large amounts of RANTES aggregated on the cell surface, which led to cell activation, including up-regulation of cell surface markers, and secretion of IFN-
and macrophage inflammatory protein (MIP)-1ß. Specific inhibitors of RANTES-induced activation, such as soluble glycosaminoglycans, MIP-1
and MIP-1ß, acted by preventing the binding of RANTES on the cell surface. These studies suggest that RANTES acted more like a mitogen than an antigen-independent activator.
Keywords: activation, CD8+ T cells, chemokines, glycosaminoglycans, inhibitors, macrophage inflammatory protein
Transmitting editor: P. Beverley
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. B. Fredriksen and B. Bogen Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences Blood, September 15, 2007; 110(6): 1797 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nomura, K. Ishii, Y. Kamitsuji, N. Uoshima, E. Ishikawa, H. Kitayama, and K. Hayashi Elevation of Activated Platelet-Dependent Chemokines in Patients With Anti-CD20 Monoclonal Antibody (Rituximab)-Treated Non-Hodgkin's Lymphoma Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 206 - 212. [Abstract] [PDF]
|
|
|
|
 |
|
 T. T. Murooka, M. M. Wong, R. Rahbar, B. Majchrzak-Kita, A. E. I. Proudfoot, and E. N. Fish CCL5-CCR5-mediated Apoptosis in T Cells: REQUIREMENT FOR GLYCOSAMINOGLYCAN BINDING AND CCL5 AGGREGATION J. Biol. Chem., September 1, 2006; 281(35): 25184 - 25194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Jones, R. P. Hart, and P. G. Popovich Molecular Control of Physiological and Pathological T-Cell Recruitment after Mouse Spinal Cord Injury J. Neurosci., July 13, 2005; 25(28): 6576 - 6583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Skwor, H. Cho, C. Cassidy, T. Yoshimura, and D. N. McMurray Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages J. Leukoc. Biol., December 1, 2004; 76(6): 1229 - 1239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Lau, C. D. Paavola, Z. Johnson, J.-P. Gaudry, E. Geretti, F. Borlat, A. J. Kungl, A. E. Proudfoot, and T. M. Handel Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1: IMPLICATIONS FOR STRUCTURE AND FUNCTION IN VIVO J. Biol. Chem., May 21, 2004; 279(21): 22294 - 22305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Veillard, B. Kwak, G. Pelli, F. Mulhaupt, R. W. James, A. E.I. Proudfoot, and F. Mach Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice Circ. Res., February 6, 2004; 94(2): 253 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Roscic-Mrkic, M. Fischer, C. Leemann, A. Manrique, C. J. Gordon, J. P. Moore, A. E. I. Proudfoot, and A. Trkola RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement Blood, August 15, 2003; 102(4): 1169 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L.-Y. Chang, C. J. Gordon, B. Roscic-Mrkic, C. Power, A. E. I. Proudfoot, J. P. Moore, and A. Trkola Interaction of the CC-Chemokine RANTES with Glycosaminoglycans Activates a p44/p42 Mitogen-Activated Protein Kinase-Dependent Signaling Pathway and Enhances Human Immunodeficiency Virus Type 1 Infectivity J. Virol., March 1, 2002; 76(5): 2245 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Garba, C. D. Pilcher, A. L. Bingham, J. Eron, and J. A. Frelinger HIV Antigens Can Induce TGF-{beta}1-Producing Immunoregulatory CD8+ T Cells J. Immunol., March 1, 2002; 168(5): 2247 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Fischer, Y. Luo, M. Luo, L. Santambrogio, and M. E. Dorf RANTES-Induced Chemokine Cascade in Dendritic Cells J. Immunol., August 1, 2001; 167(3): 1637 - 1643. [Abstract] [Full Text] [PDF]
|
|